5% glucose injection
Sponsors
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Beijing Anzhen Hospital, Zhujiang Hospital, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Beijing Inno Medicine Co., Ltd.
Conditions
Acute Heart FailureAcute Respiratory Distress SyndromeAtherosclerotic Cardiovascular Disease (ASCVD)Erectile DysfunctionMyocardial InfarctionRight Ventricular DysfunctionSepsisSeptic Shock
Phase 2
Clinical Efficacy of Megadose Vitamin C in Sepsis
CompletedNCT05194189
Start: 2022-02-08End: 2024-12-25Updated: 2026-05-13
Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV
NCT05768230
Start: 2023-03-22End: 2025-12-01Target: 58Updated: 2023-03-14
Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction
Not yet recruitingNCT07311330
Start: 2026-01-31End: 2026-11-14Target: 40Updated: 2025-12-30
Phase 4
A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure
CompletedNCT02135835
Start: 2014-09-03End: 2017-03-24Updated: 2018-03-01
ShenFu Injection for Myocardial Protection in Patients With Acute ST Segment Elevation Myocardial Infarction
CompletedNCT02709798
Start: 2016-04-30End: 2018-02-28Updated: 2018-08-07
Randomized Evaluation of Shenfu Injection to Reduce Myocardial Injury
NCT04493840
Start: 2020-07-30End: 2022-08-31Target: 326Updated: 2021-09-10